[phil]

speak to asupervisor , take name, record of call, get a copy of their coverage rules regarding perjeta. fda approval is for pts who have not had prior anti - her2 therapy, but many ins. co.'s are approving it, like that bc/bs mentioned. docs can prescribe it for stage iv's who have had prior anti -her2 tx., its called " off protocol or off label " . the fda pt reps tell pts this , they understand their appr. process is not keeping up w/ new tx.'s. their top execs , all dr's ( amazing ) pazdur, woodcock, hamburg, are too far removed from the chemo room reality. their fda has " no timetable " right now to "expand label " . this is crux of our activism. we stage ivs have no voice at top of fda.
so we fight . push the ins. co., for a week or so, appeal any denial. then go to your Congressional reps, and media. are u at a top research hospital , dealing w/ latest triple pos., which it looks like u are ? your doc doesn't sound like a top researcher .